Review Report on CD4 Target / Biomarker Content of Review Report on CD4 Target / Biomarker
CD4
Other Name(s): CD4 variant 2 | CD4_HUMAN | T-cell surface glycoprotein CD4 (isoform 2) | CD4 antigen (p55) | CD4 molecule | IMD79 | CD4 variant 1 | OKT4D | T-cell surface antigen T4/Leu-3 | p55 | CD4mut | CD4 molecule, transcript variant 1 | T-cell surface glycoprotein CD4 | T-cell surface glycoprotein CD4 (isoform 1) | CD4 molecule, transcript variant 2 | CD4 receptor

CD4 in HIV infection and evasion of the host immune system

HIV-1 infected macrophages exhibit resistance to cell-mediated killing and apoptosis, as the virus upregulates certain factors to evade these mechanisms. Furthermore, HIV-1 induces mechanisms to evade interferon (IFN) responses in infected macrophages through various accessory proteins.

CD4+ T cells have the ability to enter the central nervous system (CNS) through multiple routes, including migration through the endothelial blood vessels of the choroid plexus, access via the subarachnoid and perivascular spaces, and direct crossing of the microvascular endothelium at the blood-brain barrier (BBB) under inflammatory conditions. In the CNS, activated CD4+ T cells can interact with various cells and tissues, potentially contributing to the pathogenesis of conditions such as multiple sclerosis.

In the context of HIV and Mtb co-infection, HIV leads to a depletion of CD4+ T cells, compromising immune function in the gastrointestinal tract and resulting in immune activation and microbial translocation. The breakdown of granulomas caused by HIV infection promotes Mtb reactivation and breach of containment. Concurrent therapy with isoniazid and/or IL-21 has been suggested to address both bacterial containment and immune activation.

The pathogenesis of HIV does not directly involve free HIV particles killing CD4 T cells. Instead, the small fraction of permissive cells that become productively infected mediate cell-to-cell spread, leading to the death of nonpermissive CD4 T cells. The interaction of LFA-1 on T cells with ICAM-1 contributes to HIV pathogenesis by promoting CD4 T cell depletion and chronic inflammation.

In the context of latent tuberculosis infection (LTBI), co-infection with SIV leads to immunosuppression and a decrease in CD4+ T cell counts. This disruption in the immune system balance results in chronic immune activation, dysbiosis, and reactivation of LTBI. SIV-induced immune perturbation also reduces the generation of lung-homing Mtb-specific TEM CD4+ T cells, leading to the disintegration of granulomas and dissemination of Mtb.

Therefore, CD4 is involved in various aspects of HIV pathogenesis, immune responses, and co-infections, highlighting its critical role in the immune system's function and the development of related diseases.
Based on the given context, here are some key viewpoints regarding CD4:

CD4+ cells play a significant role in the immune response, and their gene expression can change after treatment with certain drugs like fingolimod.
Resting CD4+ T cells are relatively resistant to HIV-1 infection, but after activation, they become susceptible to viral entry and productive infection. Infection during the transition from effector to memory cells can lead to latent infection.
Killing latently infected CD4+ T cells poses challenges in HIV-1 cure strategies, including escape mutations, inhibition of CTL function, and exhaustion of HIV-1-specific CTLs.
Autophagy is crucial for maintaining the stability and immunosuppressive functions of CD4 Treg cells, and its deficiency can lead to dysregulation of pathways and loss of regulatory functions.
CD8 T cells can have both regulatory and pathogenic functions in multiple sclerosis (MS), where regulatory CD8 T cells suppress immune responses while pathogenic CD8 T cells can cause damage in the central nervous system.

Protein Name: CD4 Molecule

Functions: Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class II molecule:peptide complex. The antigens presented by class II peptides are derived from extracellular proteins while class I peptides are derived from cytosolic proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class II presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of T-helper cells. In other cells such as macrophages or NK cells, plays a role in differentiation/activation, cytokine expression and cell migration in a TCR/LCK-independent pathway. Participates in the development of T-helper cells in the thymus and triggers the differentiation of monocytes into functional mature macrophages

The "CD4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16